News Releases

Date Title and Summary
Toggle Summary electroCore to Participate in the LD Micro Main Event XVI Conference
ROCKAWAY, N.J. , Sept. 25, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger , will present at the LD Micro Main Event XVI Conference in Los Angeles, California from October 3 –
Toggle Summary electroCore to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference
ROCKAWAY, NJ , July 09, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger , CEO will present a company overview and be available for 1x1 meetings at the following upcoming conference: Ladenburg Thalmann
Toggle Summary electroCore to Participate in the JMP Securities MedTech Bio Summit
BASKING RIDGE, N.J. , Sept. 23, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc.  (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger , chief executive officer, will participate in a fireside chat at the JMP Securities MedTech Bio Summit, which is being
Toggle Summary electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC
ROCKAWAY, N.J. , June 14, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger , will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted
Toggle Summary electroCore to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
ROCKAWAY, N.J. , Sept. 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger , will present at the H.C. Wainwright 25th Annual Global Investment Conference . H.C.
Toggle Summary electroCore to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
ROCKAWAY, N.J. , Feb. 03, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that management will participate in a fireside chat at the BTIG Virtual MedTech, Digital Health , Life Science & Diagnostic Tools Conference ,
Toggle Summary electroCore to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
ROCKAWAY, N.J. , Nov. 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger , is scheduled to attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services
Toggle Summary electroCore to Participate at Upcoming Investor Conferences
ROCKAWAY, N.J. , May 18, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger , will be presenting at the H.C. Wainwright Global Investment Conference and LD Micro
Toggle Summary electroCore to Participate at Upcoming Investor Conferences
ROCKAWAY, NJ , Sept. 23, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a corporate presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference .  The
Toggle Summary electroCore to Participate at Upcoming Investor Conferences
ROCKAWAY, N.J. , Sept. 06, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger , will be participating at the H.C. Wainwright 24th Global Investment Conference and